Sunday, 20 October 2019

AB Sciex, Beckman fuse chromatography business

22 July 2013 | News | By BioSpectrum Bureau

AB Sciex and Beckman Coulter Life Sciences join hands

AB Sciex and Beckman Coulter Life Sciences join hands

Singapore: AB Sciex has combined its chromatography business with the capillary electrophoresis (CE) business from Beckman Coulter Life Sciences in order to advance separations science. The collaboration brings together Beckman Coulter's expertise in microscale separation with the expertise in microfluidics of the Eksigent chromatography team of AB Sciex.

This combination includes the transition of personnel as well as CE technologies and resources from Beckman Coulter Life Sciences to AB Sciex. Both the firms are owned by Danaher Corporation. This new alignment will enable better serving of customers while addressing analytical challenges with powerful scientific strategies that take advantage of complementary technologies.

By the end of Q3, the AB Sciex separations business will manage both the standalone Beckman Coulter CE products and the integrated CE-MS technology. The CE products will continue to be branded 'Beckman Coulter'. The separations business will also continue to manage all chromatography products, including Eksigent nano LC and micro LC systems, chips, software and columns.

"We are bringing together the best in CE with the best in nano LC and micro LC as a unified team to broaden the range of solutions available to our customers," said Mr Rainer Blair, president, AB Sciex.

"By integrating the Beckman Coulter CE team into the AB Sciex separations business, we will be able to take CE and our chromatography solutions to a whole new level. We are committed to investing in our separations business for long-term success," he added.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Is Asia-Pacific dominating the global digital transformation in healthcare market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls